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Abstract
Introduction: Several studies shows that abnormal laboratory parameters such as 
anemia, and thrombocytopenia and Leukocytosis can be a risk factor for increased 
mortality in patients referred with COPD exacerbations. They can be modified to help 
patients and it will be helpful for removal for associated complications. This study intends 
to conduct a study of the case - control and retrospective effect of this factor in causing 
mortality show.
Materials and Methods: In this case-control study, two groups of 844 COPD patients 
admitted to Imam Khomeini Hospital of Ardabil during the years 1388 to 1393 were 
selected 137 of them were cases (the COPD patients who died and had no exclusion 
criteria which is defined in the study) and 274 of them were controls (COPD patients 
discharged with a good general mood). Both cases and controls were studied in terms of 
factors such as anemia, thrombocytopenia and leukocytosis.
Results: The results showed comorbid anemia causes mortality in COPD patients. Also, it 
was shown that with increasing age, the incidence of anemia in patients with COPD gets 
higher. It was also found that leukocytosis occurs in older patients with COPD. The study 
also showed that, high admission PAP and low admission SaO2, makes the prognosis of 
COPD worse (P < 0/05).
Conclusion: The results of this study support the assumption that anemia increases the 
mortality of patients with COPD. High PAP and low SaO2 introduced as risk factors for 
increased COPD mortality. The results are in line with with other studies in Iran and the 
world.
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